Registration for the 3rd Tumor Myeloid-Directed Therapies Summit is now closed. Thank you Thank you to our Speakers, Sponsors & Delegates for joining us!
Register your interest to be the first to hear updates about the 2024 meeting
Delivering Safer, More Effective & Globally Accessible Cell Therapies to Patients at Scale
Beacon's cell therapy database covers trial and drug records for preclinical, active, approved, and discontinued CAR (chimeric antigen receptor) modified therapies, TCR (T-Cell Receptor) therapies, natural killer cells, tumor-infiltrating lymphocytes cytokine-induced killer cells, dendritic cells, and macrophages.
A vital year-round experience-sharing and problem-solving network to help drug developers make better cell therapy decisions.
A trusted provider of market intelligence for anyone looking to understand the complexities of cell therapy research and development.